353 related articles for article (PubMed ID: 33472268)
21. Comparative fibrinolytic activity of front-loaded alteplase and the single-bolus mutants tenecteplase and lanoteplase during treatment of acute myocardial infarction.
Al-Shwafi KA; de Meester A; Pirenne B; Col JJ
Am Heart J; 2003 Feb; 145(2):217-25. PubMed ID: 12595837
[TBL] [Abstract][Full Text] [Related]
22. Thrombolytics in acute ischaemic stroke: historical perspective and future opportunities.
Röther J; Ford GA; Thijs VN
Cerebrovasc Dis; 2013; 35(4):313-9. PubMed ID: 23615379
[TBL] [Abstract][Full Text] [Related]
23. [Intravenous thrombolysis in ischemic stroke: Therapeutic perspectives].
Paris C; Derex L
Rev Neurol (Paris); 2015 Dec; 171(12):866-75. PubMed ID: 26563662
[TBL] [Abstract][Full Text] [Related]
24. Acute Treatment of Ischemic Stroke.
Lyden S; Wold J
Neurol Clin; 2022 Feb; 40(1):17-32. PubMed ID: 34798968
[TBL] [Abstract][Full Text] [Related]
25. Comprehensive Review of Tenecteplase for Thrombolysis in Acute Ischemic Stroke.
Wang L; Hao M; Wu N; Wu S; Fisher M; Xiong Y
J Am Heart Assoc; 2024 May; 13(9):e031692. PubMed ID: 38686848
[TBL] [Abstract][Full Text] [Related]
26. Implementation of Tenecteplase for Acute Ischemic Stroke Treatment.
Brown CS; Manuel FC; Mattson AE; Schmitt CJ; Hellickson JD; Clark SL; Wieruszewski ED
J Emerg Nurs; 2024 Mar; 50(2):171-177. PubMed ID: 38069957
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and Safety of Intravenous Tenecteplase Bolus in Acute Ischemic Stroke: Results of Two Open-Label, Multicenter Trials.
Ramakrishnan TCR; Kumaravelu S; Narayan SK; Buddha SS; Murali C; Majeed PHA; Meenakshi-Sundaram S; Wadia RS; Sharma V; Basu I; Vijaya P; Salam KA; Barmare S; Vaid Z; Nirmal Raj KK; Wattamwar PR; Asokan K; Dhonge V; Nellikunja S; Namjoshi D; Srinivasa R; Laddhad DS; Deshpande SD; Raghunath B; Kalita J; Kumar M; Misra UK; Pradeep M;
Am J Cardiovasc Drugs; 2018 Oct; 18(5):387-395. PubMed ID: 29948822
[TBL] [Abstract][Full Text] [Related]
28. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke.
Clark WM; Wissman S; Albers GW; Jhamandas JH; Madden KP; Hamilton S
JAMA; 1999 Dec; 282(21):2019-26. PubMed ID: 10591384
[TBL] [Abstract][Full Text] [Related]
29. Safety and Efficacy of Tenecteplase in Older Patients With Large Vessel Occlusion: A Pooled Analysis of the EXTEND-IA TNK Trials.
Yogendrakumar V; Churilov L; Mitchell PJ; Kleinig TJ; Yassi N; Thijs V; Wu TY; Shah DG; Ng FC; Dewey HM; Wijeratne T; Yan B; Desmond PM; Parsons MW; Donnan GA; Davis SM; Campbell BCV;
Neurology; 2022 Mar; 98(12):e1292-e1301. PubMed ID: 35017305
[TBL] [Abstract][Full Text] [Related]
30. Update of Intravenous Thrombolytic Therapy in Acute Ischemic Stroke.
Tsai LK; Jeng JS
Acta Neurol Taiwan; 2021 Jun; 30(2)():44-53. PubMed ID: 34549389
[TBL] [Abstract][Full Text] [Related]
31. Safety and efficacy of tenecteplase versus alteplase in patients with acute ischaemic stroke (TRACE): a multicentre, randomised, open label, blinded-endpoint (PROBE) controlled phase II study.
Li S; Pan Y; Wang Z; Liang Z; Chen H; Wang D; Sui Y; Zhao X; Wang Y; Du W; Zheng H; Wang Y
Stroke Vasc Neurol; 2022 Feb; 7(1):47-53. PubMed ID: 34429364
[TBL] [Abstract][Full Text] [Related]
32. Choosing the Correct "-ase" in Acute Ischemic Stroke: Alteplase, Tenecteplase, and Reteplase.
Dillon GM; Stevens S; Dusenbury WL; Massaro L; Toy F; Purdon B
Adv Emerg Nurs J; 2019; 41(3):271-278. PubMed ID: 31356253
[TBL] [Abstract][Full Text] [Related]
33. [Intravenous thrombolysis of ischemic stroke-Current status].
Ringleb P; Bauer G; Purrucker J
Nervenarzt; 2023 Jun; 94(6):551-563. PubMed ID: 37249597
[TBL] [Abstract][Full Text] [Related]
34. Multicenter exploration of tenecteplase transition factors: A quantitative analysis.
Prasad S; Jones EM; Gebreyohanns M; Kwon Y; Olson DM; Anderson JA; Savitz SI; Cruz-Flores S; Warach SJ; Rhodes CE; Goldberg MP; Ifejika NL
J Stroke Cerebrovasc Dis; 2024 Apr; 33(4):107592. PubMed ID: 38266690
[TBL] [Abstract][Full Text] [Related]
35. Issues in the assessment of the safety and efficacy of tenecteplase (TNK-tPA).
Gibson CM; Marble SJ
Clin Cardiol; 2001 Sep; 24(9):577-84. PubMed ID: 11558838
[TBL] [Abstract][Full Text] [Related]
36. Determining the optimal dose of tenecteplase before endovascular therapy for ischemic stroke (EXTEND-IA TNK Part 2): A multicenter, randomized, controlled study.
Campbell BC; Mitchell PJ; Churilov L; Yassi N; Kleinig TJ; Yan B; Thijs V; Desmond PM; Parsons MW; Donnan GA; Davis SM
Int J Stroke; 2020 Jul; 15(5):567-572. PubMed ID: 31564231
[TBL] [Abstract][Full Text] [Related]
37. A practice game changer: Impact of tenecteplase for acute ischemic stroke in a multicenter quality improvement project.
Noh L; Pham F; Haddad L; Burkhard T; Paletz L; Pech M; Lewis M; Manoukian V; Schlick KH; Song S
Am J Health Syst Pharm; 2022 Apr; 79(9):e149-e153. PubMed ID: 35037028
[TBL] [Abstract][Full Text] [Related]
38. Tenecteplase versus Alteplase for Stroke Thrombolysis Evaluation Trial in the Ambulance (Mobile Stroke Unit-TASTE-A): protocol for a prospective randomised, open-label, blinded endpoint, phase II superiority trial of tenecteplase versus alteplase for ischaemic stroke patients presenting within 4.5 hours of symptom onset to the mobile stroke unit.
Bivard A; Zhao H; Coote S; Campbell B; Churilov L; Yassi N; Yan B; Valente M; Sharobeam A; Balabanski A; Dos Santos A; Ng F; Langenberg F; Stephenson M; Smith K; Bernard S; Thijs V; Cloud G; Choi P; Ma H; Wijeratne T; Chen C; Olenko L; Davis SM; Donnan GA; Parsons M
BMJ Open; 2022 Apr; 12(4):e056573. PubMed ID: 35487712
[TBL] [Abstract][Full Text] [Related]
39. Tenecteplase in Pediatric Stroke: Ready or Not.
Wilson JL; Waak M; Barry M; Jordan LC; Sun LR
Pediatr Neurol; 2024 Feb; 151():17-20. PubMed ID: 38070460
[TBL] [Abstract][Full Text] [Related]
40. Association of Time to Thrombolysis With Early Reperfusion After Alteplase and Tenecteplase in Patients With Large Vessel Occlusion.
Yogendrakumar V; Beharry J; Churilov L; Pesavento L; Alidin K; Ugalde M; Weir L; Mitchell PJ; Kleinig TJ; Yassi N; Thijs VN; Wu TY; Brown H; Dewey HM; Wijeratne T; Yan B; Sharma GJ; Desmond P; Parsons MW; Donnan GA; Davis SM; Campbell BCV;
Neurology; 2024 Apr; 102(7):e209166. PubMed ID: 38502892
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
